Sensitivity analysis on an AC600 aluminum skin component

New materials are been introduced on the car body in order to reduce weight and fulfil the international CO2 emission regulations. Among them, the application of aluminum alloys is increasing for skin panels. Even if these alloys are beneficial for the car design, the manufacturing of these components become more complex. In this regard, numerical simulations have become a necessary tool for die designers. There are multiple factors affecting the accuracy of these simulations e.g. hardening, anisotropy, lubrication, elastic behavior. Numerous studies have been conducted in the last years on high strength steels component stamping and on developing new anisotropic models for aluminum cup drawings. However, the impact of the correct modelling on the latest aluminums for the manufacturing of skin panels has been not yet analyzed. In this work, first, the new AC600 aluminum alloy of JLR-Novelis is characterized for anisotropy, kinematic hardening, friction coefficient, elastic behavior. Next, a sensitivity analysis is conducted on the simulation of a U channel(with drawbeads). Then, the numerical an experimental results are correlated in terms of springback and failure. Finally, some conclusions are drawn

SemEval-2017 Task 1: semantic textual similarity - multilingual and cross-lingual focused evaluation

Semantic Textual Similarity (STS) measures the meaning similarity of sentences. Applications include machine translation (MT), summarization, generation, question answering (QA), short answer grading, semantic search, dialog and conversational systems. The STS shared task is a venue for assessing the current state-of-the-art. The 2017 task focuses on multilingual and cross-lingual pairs with one sub-track exploring MT quality estimation (MTQE) data. The task obtained strong participation from 31 teams, with 17 participating in all language tracks. We summarize performance and review a selection of well performing methods. Analysis highlights common errors, providing insight into the limitations of existing models. To support ongoing work on semantic representations, the STS Benchmark is introduced as a new shared training and evaluation set carefully selected from the corpus of English STS shared task data (2012-2017)

Meaningful results for Information Retrieval in the MEANING project

The goal of the MEANING project (IST-2001-34460) is to develop tools for the automatic acquisition of lexical knowledge that will help Word Sense Disambiguation (WSD). The acquired lexical knowledge from various sources and various languages is stored in the Multilingual Central Repository (MCR) (Atserias et al 04), which is based on the design of the EuroWordNet database. The MCR holds wordnets in various languages (English, Spanish, Italian, Catalan and Basque), which are interconnected via an Inter-Lingual-Index (ILI). In addition, the MCR holds a number of ontologies and domain labels related to al

HDAC inhibitors in acute myeloid leukemia

Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled proliferation, differentiation arrest, and accumulation of immature myeloid progenitors. Although clinical advances in AML have been made, especially in young patients, long-term disease-free survival remains poor, making this disease an unmet therapeutic challenge. Epigenetic alterations and mutations in epigenetic regulators contribute to the pathogenesis of AML, supporting the rationale for the use of epigenetic drugs in patients with AML. While hypomethylating agents have already been approved in AML, the use of other epigenetic inhibitors, such as histone deacetylases (HDAC) inhibitors (HDACi), is under clinical development. HDACi such as Panobinostat, Vorinostat, and Tricostatin A have been shown to promote cell death, autophagy, apoptosis, or growth arrest in preclinical AML models, yet these inhibitors do not seem to be effective as monotherapies, but rather in combination with other drugs. In this review, we discuss the rationale for the use of different HDACi in patients with AML, the results of preclinical studies, and the results obtained in clinical trials. Although so far the results with HDACi in clinical trials in AML have been modest, there are some encouraging data from treatment with the HDACi Pracinostat in combination with DNA demethylating agents